How Pharmacists' Awareness of Sterile Compounding Procedures Changed Since 2012 Meningitis Outbreak
February 27th 2015Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how pharmacists' awareness of sterile compounding procedures has changed since the 2012 meningitis outbreak.
Cardinal Health's GenerationRx Program Raises Awareness of Prescription Drug Abuse
February 26th 2015Ludy L. Underwood, Cardinal Health sales manager for retail/alternative care, pharmaceutical division, talks about how Cardinal Health's Generation Rx program raises awareness of prescription drug abuse.
How Pharmacists can Use Expertise to Overcome Negative Stereotypes About Compounding
February 26th 2015Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how pharmacists can use their expertise to overcome negative stereotypes surrounding compounding.
The Challenge of Getting Specialty Drugs from Manufacturer to Patient
February 25th 2015Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses how to overcome the hurdles that hinder patient access to specialty medications.
Specialty Pharmacy Programs in a Community Pharmacy Space Offer Advantages to Community Operations
February 25th 2015Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, talks about advantages that a specialty pharmacy program in the community pharmacy space offers for traditional community operations.
FDA's Compounding Advisory Committee's Effects for Compounding Pharmacists
February 25th 2015Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA's Compounding Advisory Committee will affect the daily practice of compounding pharmacists.